BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31100498)

  • 41. Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon.
    Tekwu EM; Sidze LK; Assam JP; Tedom JC; Tchatchouang S; Makafe GG; Wetewale AL; Kuaban C; Eyangoh S; Ntoumi F; Beng VN; Frank M
    BMC Microbiol; 2014 May; 14():113. PubMed ID: 24884632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis on drug resistance-associated mutations of multi-drug resistant
    Gao M; Yang TT; Li GL; Chen R; Liu HC; Gao Q; Wan KL; Feng SD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):770-775. PubMed ID: 32447923
    [No Abstract]   [Full Text] [Related]  

  • 43. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
    Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
    J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.
    Perdigão J; Macedo R; Machado D; Silva C; Jordão L; Couto I; Viveiros M; Portugal I
    Clin Microbiol Infect; 2014 May; 20(5):O278-84. PubMed ID: 24102832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype analysis of ofloxacin-resistant multidrug-resistant
    Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
    Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of
    Assis Figueredo LJ; de Almeida IN; Augusto CJ; Soares VM; Suffys PN; Carvalho WDS; de Miranda SS
    Int J Mycobacteriol; 2020; 9(4):368-372. PubMed ID: 33323651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of novel
    Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
    Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
    Dantas NG; Suffys PN; Carvalho Wda S; Gomes HM; de Almeida IN; de Assis LJ; Augusto CJ; Gomgnimbou MK; Refregier G; Sola C; de Miranda SS
    BMC Infect Dis; 2015 Aug; 15():306. PubMed ID: 26231661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.
    Lemus D; Echemendía M; Díaz R; Llanes MJ; Suárez L; Marrero A
    MEDICC Rev; 2017 Jan; 19(1):10-15. PubMed ID: 28225540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
    Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
    Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of mutations conferring streptomycin resistance to multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Thida Oo NA; San LL; Thapa J; Aye KS; Aung WW; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2018 Jul; 111():8-13. PubMed ID: 30029920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico.
    Lopez-Avalos G; Gonzalez-Palomar G; Lopez-Rodriguez M; Vazquez-Chacon CA; Mora-Aguilera G; Gonzalez-Barrios JA; Villanueva-Arias JC; Sandoval-Diaz M; Miranda-Hernández U; Alvarez-Maya I
    J Glob Antimicrob Resist; 2017 Dec; 11():90-97. PubMed ID: 28760681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil.
    Dalla Costa ER; Vasconcelos SE; Esteves LS; Gomes HM; Gomes LL; da Silva PA; Perdigão J; Portugal I; Viveiros M; McNerney R; Pain A; Clark TG; Rastogi N; Unis G; Rossetti ML; Suffys PN
    J Clin Microbiol; 2015 Dec; 53(12):3805-11. PubMed ID: 26400784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Exploratory study on detection of drug resistance of
    Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379
    [No Abstract]   [Full Text] [Related]  

  • 57. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
    Zhang D; Liu B; Wang Y; Pang Y
    Trop Med Int Health; 2014 Oct; 19(10):1259-66. PubMed ID: 25040060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
    Shi D; Li L; Zhao Y; Jia Q; Li H; Coulter C; Jin Q; Zhu G
    J Antimicrob Chemother; 2011 Oct; 66(10):2240-7. PubMed ID: 21778195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil.
    Salvato RS; Schiefelbein S; Barcellos RB; Praetzel BM; Anusca IS; Esteves LS; Halon ML; Unis G; Dias CF; Miranda SS; de Almeida IN; de Assis Figueredo LJ; Silva EC; Kritski AL; Dalla Costa ER; Rossetti MLR
    Epidemiol Infect; 2019 Jan; 147():e216. PubMed ID: 31364547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.